So... uh, what is it? We follow the clues in ads for Real Wealth Strategist to get you some answers
24 Comments Read MoreArticles
“America’s ‘Infinite Oil Well’ — Matt Badiali teases that “Revolutionary New Technology Could Unlock a Potential $70 TRILLION Windfall”
Irregulars Annual Review
Annual Review
Taking a quick look and updating my thoughts on (almost) every stock in the "Gumshoe Universe"
16 Comments Read MoreAnnual Review — Watchlist
Warrants, Sprott, Markel and some Personal Trades — a Friday File Hodgepodge
I have a few thoughts to share with my favorite Irregulars today for our Friday File (we also shared a new article from Doc Gumshoe earlier today if you’re interested). Today we’re looking at a few trades I’ve made this week (four buys and one sell), updating thoughts on a couple companies I’ve covered before, […]
8 Comments Read MoreDrillers and Pumpers
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
From Biotime's recent press release: BioTime has developed Hextend(R), a blood plasma volume expander for use in surger...
Anyone think now might be a good time to buy?...
It appears that Travis did not uncover evidence that this company has an industry note worthy tech advancement to suppo...
CJ might be a good company, but Argus Research and Ford Equity have sell ratings on the stock....
Thanks for your assessment on CJ Travis. I researched this area for opportunities a while back and found what may be a ...
I'm doubtful of C&J doing anything other than tracking the index, as it has done in the past. If it had showed an ab...
Travis, you nailed this one. C&J will continue to trade in line with WTI. Watch to see if they bring back up any o...